Last updated: 2026-09-06 14:28:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Precipio, Inc. (PRPO) operates in the LABORATORY ANALYTICAL INSTRUMENTS sector and is listed on NASDAQ. The stock is currently priced at $27.21, with a market capitalization of $49.23M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $15.80 to $33.63. This page covers its latest market performance, valuation, price trends and company information.
$49.23M | |
$26.11 | |
$8,448.00 | |
$3.90 | |
$26.12 | |
113.94K | |
-- | |
-- | |
$33.63 | |
$15.80 | |
-- | |
-- |
Precipio, Inc. (PRPO) last closed at $26.12 as of 2026-09-04 23:31:00, unchanged from the previous close of $26.12.
During the latest regular trading session, PRPO traded between $3.90 and $8,448.00, with a volume of 113.94K shares. The closing price was near the lower end and near the middle of its 52-week range.
Over the past seven days, Precipio, Inc. (PRPO) moved from $28.85 to $27.21, representing a decline of 5.69% ($1.64).
The stock traded between $24.60 and $27.74 during the period. The latest price is near the upper end of the 7-day range, indicating strong downward.
The average daily volume was 188.99 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 64.0%
PRPO is currently trading at $27.21, placing it 64.0% of the way from its 52-week low of $15.80 to its 52-week high of $33.63. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
| Industry | LABORATORY ANALYTICAL INSTRUMENTS |
| Employees | 71 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Precipio, Inc. (PRPO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.